Pfizer to buy Anacor Pharma in $5.2 bn deal

Pfizer Inc will buy Anacor Pharmaceuticals Inc in a $5.2-billion (£3.61 billion). This deal comes just after a month when US drug major scrapped plans to acquire Allergan Plc. Now Pfizer is all set to add an eczema gel to its portfolio with the help of this acquition. The equity value of the deal is $4.45 billion, based on 44.87 million Anacor’s outstanding fully diluted shares as of March 31.

The acquisition will give Pfizer access to a non-steroidal topical gel, crisaborole, which is currently under review by the US Food and Drug Administration for the treatment of mild to moderate eczema and as per the American global pharmaceutical corporation, Pfizer, the crisaborole had the potential to reach or exceed peak sales of $2 billion.

So let’s discuss some questions related to this post :
1. Name the company which is all set to buy the Anacor Pharma in $5.2 bn deal ?
2. The global pharmaceutical corporation, Pfizer is from which country ?


Courtesy : Business Standard

×

Download success!

Thanks for downloading the guide. For similar guides, free study material, quizzes, videos and job alerts you can download the Adda247 app from play store.

[adda247_lead_form]

Leave a comment

Your email address will not be published. Required fields are marked *